Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,218 hedge funds and large institutions have $60.3B invested in Celgene Corp in 2016 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 502 increasing their positions, 476 reducing their positions, and 75 closing their positions.
11% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 75
5% more repeat investments, than reductions
Existing positions increased: 502 | Existing positions reduced: 476
0% less funds holding
Funds holding: 1,224 → 1,218 (-6)
1% less capital invested
Capital invested by funds: $61B → $60.3B (-$770M)
2% less call options, than puts
Call options by funds: $963M | Put options by funds: $983M
13% less funds holding in top 10
Funds holding in top 10: 85 → 74 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$303M |
| 2 |
CG
Carmignac Gestion
Paris,
France
|
+$220M |
| 3 |
Lazard Asset Management
New York
|
+$129M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$109M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$104M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
-$1.97B |
| 2 |
JP Morgan Chase
New York
|
-$428M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$315M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$189M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$179M |
CELG Hedge Fund Activity: Q2 2016 in Review
1,218 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2016, worth a combined $60.3B — down 1.3% from $61B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new CELG positions and 75 closed out — a net gain of 8 holders — while 502 added to existing stakes and 476 trimmed.
The largest buyer was Macquarie Group, adding an estimated $303M. The largest seller was Royal London Asset Management, cutting an estimated $1.97B.
- 1,218 institutional investors held Celgene Corp (CELG) as of Q2 2016, down from 1,224 in Q1 2016.
- Funds reported $60.3B of Celgene Corp stock for Q2 2016, down 1.3% quarter-over-quarter.
- 83 funds opened new Celgene Corp positions in Q2 2016 and 75 closed out, a net change of +8 holders.
- The largest Celgene Corp buyer in Q2 2016 was Macquarie Group, an estimated $303M added.
- The largest Celgene Corp seller in Q2 2016 was Royal London Asset Management, an estimated $1.97B sold.
Based on aggregated 13F filings for Q2 2016.